Top compounds associated with response to LEUTX


Feature Type Standardized
Nominal ANOVA
mRNA WP1130 CTRPv2 pan-cancer AAC 0.055 0.1
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.053 0.1
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.1
mRNA foretinib GDSC1000 pan-cancer AAC -0.05 0.1
mRNA MLN4924 CTRPv2 pan-cancer AAC -0.053 0.1
mRNA HG-6-64-1 GDSC1000 pan-cancer AAC -0.052 0.1
mRNA 968 CTRPv2 pan-cancer AAC 0.11 0.1
mRNA myriocin CTRPv2 pan-cancer AAC -0.12 0.1
mRNA procarbazine CTRPv2 pan-cancer AAC 0.059 0.1
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC -0.045 0.1
Download CSV